Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deep learning framework for efficient pathology image analysis.

Nature communications·2026
Same author

Evaluating statistical models for overdispersed multi-omics data: a multiplex immunofluorescence case study.

American journal of epidemiology·2026
Same author

Shared genetic architecture between obesity and psychiatric disorders reveals comorbid etiology and therapeutic targets.

Life medicine·2026
Same author

The role of gastric atrophy in the association between Helicobacter pylori infection and esophageal adenocarcinoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Spatial biomarker discovery via interpretable semantic learning in histopathology.

Cancer cell·2026
Same author

Site- and age-dependent associations between Fusobacterium nucleatum and colorectal cancer mortality.

Cancer·2026

Related Experiment Video

Updated: Jun 12, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.9K

Transcriptome-wide Mendelian randomization exploring dynamic CD4+ T cell gene expression in colorectal cancer

Benedita Deslandes1,2, Xueyan Wu3,4, Matthew A Lee5

  • 1MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom.

Journal of Leukocyte Biology
|September 20, 2025
PubMed
Summary

Higher CD4+ T cell gene expression may causally influence colorectal cancer (CRC) risk. This study identifies six genes potentially impacting CRC development, highlighting the dynamic role of these immune cells in cancer prevention.

Keywords:
CD4+ T cellsMendelian randomizationcolorectal cancergene expressiongenetic epidemiology

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K

Related Experiment Videos

Last Updated: Jun 12, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.9K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K

Area of Science:

  • Immunology
  • Genetics
  • Cancer Research

Background:

  • Circulating lymphocyte counts are linked to colorectal cancer (CRC) protection, but specific roles of lymphocyte subtypes and activation states are unclear.
  • CD4+ T cells, crucial for immune response, exhibit dynamic gene expression changes upon activation, impacting their function.
  • Previous bulk tissue studies offer limited insight into the dynamic role of CD4+ T cells in CRC risk.

Purpose of the Study:

  • To investigate the causal relationships between gene expression in various CD4+ T cell subtypes and activation states and CRC risk.
  • To identify specific genes with a causal role in CRC development by analyzing gene expression data from CD4+ T cells.
  • To explore the influence of CD4+ T cell dynamics on CRC risk across different anatomical subsites and sexes.

Main Methods:

  • Applied Mendelian randomization (MR) and genetic colocalization analyses.
  • Utilized genetic proxies from single-cell transcriptomic data for 1,805 genes across CD4+ T cell activation states.
  • Analyzed a large dataset of 78,473 CRC cases and 107,143 controls, with stratification by CRC subsite and sex.

Main Results:

  • Identified six genes (FADS2, FHL3, HLA-DRB1, HLA-DRB5, RPL28, TMEM258) with significant evidence for a causal role in CRC development (FDR-P < 0.05; colocalization H4 > 0.8).
  • Observed variations in causal estimates based on CD4+ T cell subtype, activation state, CRC subsite, and sex.
  • Noted that genetic proxies for CD4+ T cell expression also function as eQTLs in other tissues, indicating challenges in assessing tissue-specific effects.

Conclusions:

  • Capturing the dynamic nature of CD4+ T cells is crucial for understanding CRC risk.
  • Prioritized six genes for further investigation in the context of cancer prevention strategies.
  • Emphasized the complexity of using genetic proxies for tissue-specific gene expression analysis in immune cells.